Stockscreener 앱 받기
2.1501
5.87%
-0.1399
전일 마감가:
$2.29
열려 있는:
$2.4
하루 거래량:
112.02K
Relative Volume:
1.19
시가총액:
$89.93M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-2.0477
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
-3.77%
1개월 성능:
-9.81%
6개월 성능:
-20.17%
1년 성능:
-12.73%
1일 변동 폭
$2.05
$2.40
1주일 범위
$2.05
$2.41
52주 변동 폭
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.1555 | 95.54M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
125.45 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.91 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
363.56 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.28 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.10 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
Transcript : InspireMD, Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Earnings call transcript: InspireMD Q3 2025 beats EPS expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: InspireMD Q3 2025 beats EPS expectations - Investing.com
InspireMD’s Sales Jump Thanks To Its Flagship Stent Launch - Finimize
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD, Inc. Q3 Loss Increases, But Beats Estimates - Nasdaq
InspireMD Reports Third Quarter 2025 Financial Results - The Manila Times
InspireMD Reports Third Quarter 2025 Financial Results - GlobeNewswire Inc.
Why analysts remain bullish on InspireMD Inc. stockTrade Risk Report & Daily Price Action Insights - newser.com
Using data filters to optimize entry into InspireMD Inc.2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Applying chart zones and confluence areas to InspireMD Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
Analyzing InspireMD (NYSE:NSPR) & Acutus Medical (NASDAQ:AFIB) - Defense World
InspireMD appoints Dr. Peter Soukas as chief medical officer By Investing.com - Investing.com Nigeria
InspireMD, Inc. Appoints Peter A. Soukas, M.D., as Chief Medical Officer - MarketScreener
Cardiologist Peter Soukas becomes chief medical officer of carotid stent company - Cardiovascular Business
Why InspireMD Inc. (II2) stock remains top ratedQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is InspireMD Inc. stock poised for growth2025 Year in Review & Stock Portfolio Risk Control - newser.com
InspireMD appoints Dr. Peter Soukas as chief medical officer - Investing.com
InspireMD Appoints Dr. Peter A. Soukas as Chief Medical Officer to Advance Carotid Intervention Initiatives - Quiver Quantitative
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer - The Manila Times
InspireMD (NASDAQ: NSPR) names Dr. Peter Soukas CMO as CGuard Prime launches in U.S. - Stock Titan
How InspireMD Inc. stock reacts to Fed rate cuts2025 Big Picture & Scalable Portfolio Growth Methods - newser.com
Can InspireMD Inc. stock weather global recessionMarket Activity Report & AI Driven Stock Reports - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersWeekly Stock Recap & High Accuracy Buy Signal Tips - newser.com
What to do if you’re stuck in InspireMD Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Short interest data insights for InspireMD Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsTrade Exit Summary & Proven Capital Preservation Tips - newser.com
Backtesting results for InspireMD Inc. trading strategiesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
What margin trends mean for InspireMD Inc. stockWeekly Stock Report & Community Consensus Stock Picks - newser.com
How InspireMD Inc. (II2) stock responds to job market shiftsEarnings Miss & Technical Entry and Exit Alerts - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollar2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Pleasing Signs As A Number Of Insiders Buy InspireMD Stock - Yahoo Finance
Is InspireMD Inc. stock a defensive play in 2025July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.22%
0.08%
자본화:
|
볼륨(24시간):